光感受器细胞和 RPE 有助于糖尿病视网膜病变的发展。
Photoreceptor cells and RPE contribute to the development of diabetic retinopathy.
机构信息
Department of Pharmacology, Case Western Reserve University, Cleveland, OH, USA.
Department of Pharmacology, Case Western Reserve University, Cleveland, OH, USA; Veterans Administration Medical Center Research Service, Cleveland, OH, USA; Gavin Herbert Eye Institute, University of California Irvine, Irvine, CA, USA; Veterans Administration Medical Center Research Service, Long Beach, CA, USA.
出版信息
Prog Retin Eye Res. 2021 Jul;83:100919. doi: 10.1016/j.preteyeres.2020.100919. Epub 2020 Nov 12.
Diabetic retinopathy (DR) is a leading cause of blindness. It has long been regarded as vascular disease, but work in the past years has shown abnormalities also in the neural retina. Unfortunately, research on the vascular and neural abnormalities have remained largely separate, instead of being integrated into a comprehensive view of DR that includes both the neural and vascular components. Recent evidence suggests that the most predominant neural cell in the retina (photoreceptors) and the adjacent retinal pigment epithelium (RPE) play an important role in the development of vascular lesions characteristic of DR. This review summarizes evidence that the outer retina is altered in diabetes, and that photoreceptors and RPE contribute to retinal vascular alterations in the early stages of the retinopathy. The possible molecular mechanisms by which cells of the outer retina might contribute to retinal vascular damage in diabetes also are discussed. Diabetes-induced alterations in the outer retina represent a novel therapeutic target to inhibit DR.
糖尿病性视网膜病变(DR)是失明的主要原因。长期以来,它一直被认为是血管疾病,但近年来的研究表明,神经视网膜也存在异常。不幸的是,对血管和神经异常的研究仍然很大程度上是分开的,而不是将其整合到包括神经和血管成分的综合 DR 视图中。最近的证据表明,视网膜中最主要的神经细胞(感光细胞)和相邻的视网膜色素上皮(RPE)在 DR 特征性血管病变的发展中起着重要作用。这篇综述总结了外视网膜在糖尿病中发生改变的证据,以及感光细胞和 RPE 在视网膜病变的早期阶段对视网膜血管改变的贡献。还讨论了外视网膜细胞可能导致糖尿病性视网膜血管损伤的可能分子机制。糖尿病引起的外视网膜改变代表了抑制 DR 的一个新的治疗靶点。
相似文献
Prog Retin Eye Res. 2021-7
Vis Neurosci. 2020-9-14
Vis Neurosci. 2020-10-6
Invest Ophthalmol Vis Sci. 2014-5-20
Drug Des Devel Ther. 2018-7-3
引用本文的文献
J Nanobiotechnology. 2025-8-20
Pharmaceuticals (Basel). 2025-6-4
World J Stem Cells. 2025-5-26
Front Endocrinol (Lausanne). 2025-5-21
本文引用的文献
Biomed Opt Express. 2020-8-7
Proc Natl Acad Sci U S A. 2020-8-26
BMJ Open Diabetes Res Care. 2020-8
Proc Natl Acad Sci U S A. 2020-8-5
Vis Neurosci. 2020-6-15
Invest Ophthalmol Vis Sci. 2020-6-3
Int J Mol Sci. 2020-2-22
Neurobiol Dis. 2020-4